Atea Pharmaceuticals, Inc. (AVIR) NASDAQ

4.62

-0.03(-0.65%)

Updated at February 25 04:00PM

Currency In USD

Valuation

Market Cap282.29M
Enterprise Value219.23M
P/E Ratio-2.48
PEG Ratio0.25
Price/Sales Ratio0
Price/Book Ratio1.16
Enterprise/Revenue0
Enterprise/EBITDA-1.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.43
Return On Equity-0.38

Income Statement

Revenue0
Revenue/Share0
Gross Profit-83.37M
EBITDA-131.8M
Net Income-168.39M
Diluted EPS-2

Balance Sheet

Total Cash329.31M
Total Cash/Share4.17
Total Debt1.05M
Total Debt/Equity0
Current Ratio16.66
Book Value Per Share3.99

Price History

52-Week Change47.13
52-Week High4.8
52-Week Low2.46
Moving Average 50 Days3.73
Moving Average 200 Days3.36

Statistics

Average Volume444,156
Shares Outstanding78.13M
% Held by Institutions71.8

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A